According to a new report from Intel Market Research, the Europe prostate cancer devices market was valued at USD 567.8 million in 2024 and is projected to grow from USD 605.0 million in 2025 to USD 845.6 million by 2030, exhibiting a robust CAGR of 6.9% during the forecast period (2025–2030). This growth is driven by an aging male population with a higher risk profile, continuous...

The healthcare industry is increasingly focusing on precision diagnostics and early disease detection, driving the adoption of advanced biopsy technologies. Smart biopsy devices have emerged as a significant innovation in diagnostic medicine, offering enhanced accuracy, real-time guidance, and improved tissue sampling capabilities. These devices integrate advanced imaging, navigation systems,...